{"id":{"repo_id":"gmu","oai_identifier":"oai:MARS:1920/12878"},"canonical_url":"https://search.dev.ndltd.org/etd/gmu/oai:MARS:1920/12878","repository":{"repo_id":"gmu","name":"George Mason University","base_url":"https://mars.gmu.edu/server/oai/request"},"display":{"title":"Relationship Between Payment Structures and Cost-Control Policy on Health Expenditures","abstract":"In 2019, the U.S. health expenditure reached 16.8% of GDP (OECD, 2021). I hypothesize that payment structure and cost-control policy lead to variation in healthcare spending. Despite an optimized payment structure, health expenditure rises without cost-control policies. An original approach is to explain the variation in healthcare spending by analyzing the Swiss and Japanese payment structure and cost-control policies to improve the sustainability of the U.S. public healthcare system. The objective is to improve the cost-effectiveness of the U.S. payment structure by looking at the Japanese and Swiss payment structures and then discuss their cost-control policies. First, the study finds that using the example of Knee and Hip Arthroplasty, the Japanese DPC incentivizes surgery less than the U.S. MS-DRG thanks to a national fee schedule to control costs. Second, the example of insulin shows that cost-control policies reduce health expenditures. Third, Japan has Long-Term Care Insurance with screening and certification to control costs. Based on the evidence and examples provided, I will prove that payment structures and cost-control policy lead to variation in healthcare spending.","abstract_html":"In 2019, the U.S. health expenditure reached 16.8% of GDP (OECD, 2021). I hypothesize that payment structure and cost-control policy lead to variation in healthcare spending. Despite an optimized payment structure, health expenditure rises without cost-control policies. An original approach is to explain the variation in healthcare spending by analyzing the Swiss and Japanese payment structure and cost-control policies to improve the sustainability of the U.S. public healthcare system. The objective is to improve the cost-effectiveness of the U.S. payment structure by looking at the Japanese and Swiss payment structures and then discuss their cost-control policies. First, the study finds that using the example of Knee and Hip Arthroplasty, the Japanese DPC incentivizes surgery less than the U.S. MS-DRG thanks to a national fee schedule to control costs. Second, the example of insulin shows that cost-control policies reduce health expenditures. Third, Japan has Long-Term Care Insurance with screening and certification to control costs. Based on the evidence and examples provided, I will prove that payment structures and cost-control policy lead to variation in healthcare spending.","abstract_has_math":false,"creators":["Karolewicz, Nicolas"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-07-27T19:52:12Z","subjects":["Expenditure","Payment","Cost-control","Health","Spending","DRG"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["hdl:1920/12878"],"render_values":[{"text":"hdl:1920/12878","href":null,"code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null},"metadata_groups":[{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Expenditure","Payment","Cost-control","Health","Spending","DRG"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["hdl:1920/12878"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.other","label":"Dc Description Other","values":["In 2019, the U.S. health expenditure reached 16.8% of GDP (OECD, 2021). I hypothesize that payment structure and cost-control policy lead to variation in healthcare spending. Despite an optimized payment structure, health expenditure rises without cost-control policies. An original approach is to explain the variation in healthcare spending by analyzing the Swiss and Japanese payment structure and cost-control policies to improve the sustainability of the U.S. public healthcare system. The objective is to improve the cost-effectiveness of the U.S. payment structure by looking at the Japanese and Swiss payment structures and then discuss their cost-control policies. First, the study finds that using the example of Knee and Hip Arthroplasty, the Japanese DPC incentivizes surgery less than the U.S. MS-DRG thanks to a national fee schedule to control costs. Second, the example of insulin shows that cost-control policies reduce health expenditures. Third, Japan has Long-Term Care Insurance with screening and certification to control costs. Based on the evidence and examples provided, I will prove that payment structures and cost-control policy lead to variation in healthcare spending."]},{"key":"dc:title","label":"Title","values":["Relationship Between Payment Structures and Cost-Control Policy on Health Expenditures"]}]}],"canonical_facts":{"dc:description.other":["In 2019, the U.S. health expenditure reached 16.8% of GDP (OECD, 2021). I hypothesize that payment structure and cost-control policy lead to variation in healthcare spending. Despite an optimized payment structure, health expenditure rises without cost-control policies. An original approach is to explain the variation in healthcare spending by analyzing the Swiss and Japanese payment structure and cost-control policies to improve the sustainability of the U.S. public healthcare system. The objective is to improve the cost-effectiveness of the U.S. payment structure by looking at the Japanese and Swiss payment structures and then discuss their cost-control policies. First, the study finds that using the example of Knee and Hip Arthroplasty, the Japanese DPC incentivizes surgery less than the U.S. MS-DRG thanks to a national fee schedule to control costs. Second, the example of insulin shows that cost-control policies reduce health expenditures. Third, Japan has Long-Term Care Insurance with screening and certification to control costs. Based on the evidence and examples provided, I will prove that payment structures and cost-control policy lead to variation in healthcare spending."],"dc:identifier":["hdl:1920/12878"],"dc:subject":["Expenditure","Payment","Cost-control","Health","Spending","DRG"],"dc:title":["Relationship Between Payment Structures and Cost-Control Policy on Health Expenditures"],"dc:type":["Thesis"]},"updated_at":"2026-07-27T19:52:12Z"}